Study title:
Anlar B, Guven A, Kose G, Okur H, Kose O, Aydin OF, Kabakus N, Altunbasak S, Herguner O, Sonmez M, Serdaroglu A. J Neuroimmunol. 2005 Jun;163(1-2):195-8. Lymphocyte subsets, TNF alpha and interleukin-4 levels in treated and untreated subacute sclerosing panencephalitis patients.Anlar B, Guven A, Kose G, Okur H, Kose O, Aydin OF, Kabakus N, Altunbasak S, Herguner O, Sonmez M, Serdaroglu A. J Neuroimmunol. 2005 Jun;163(1-2):195-8. Lymphocyte subsets, TNF alpha and interleukin-4 levels in treated and untreated subacute sclerosing panencephalitis patients.
Type of medicine: Medicines containing chemical active substances
|
Therapeutic area: Virus Diseases [C02]
|
Brands: Please see report |
MAH holders: Please see report |
Assessment: |
Active substance: INOSINE |
ATC code: |
Document link:
|
Document date:
|
Study number: |
EudraCT number:
|
Scope of study: Clinical |
Population of study subjects:
|
Preterm newborn Infants
|
Newborn infants
(1 to 27 days)
|
Infants and toddlers
(28 days to 24 months)
|
Children
(2 to 11 years)
|
Adolescents
(12 to 18 years)
|
|
-
|
-
|
-
|
Y
|
-
|